These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3285481)

  • 1. The central role of progesterone receptors and progestational agents in the management and treatment of breast cancer.
    Horwitz KB
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):14-9. PubMed ID: 3285481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progestin action and progesterone receptor structure in human breast cancer: a review.
    Horwitz KB; Wei LL; Sedlacek SM; d'Arville CN
    Recent Prog Horm Res; 1985; 41():249-316. PubMed ID: 3931189
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current aspects of hormone therapy in carcinoma of the breast].
    Sesti F; Piccione E
    Minerva Ginecol; 1987 Nov; 39(11):765-71. PubMed ID: 3328113
    [No Abstract]   [Full Text] [Related]  

  • 4. Progestin therapy for breast cancer: a panel discussion.
    McGuire WL; Cavalli F; Bonomi P; Alexieva-Figussch J
    Breast Cancer Res Treat; 1985; 6(3):213-20. PubMed ID: 4092098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin action and progesterone receptors in breast cancer.
    Chamness GC
    Cancer Res; 1989 Dec; 49(24 Pt 1):7176-9. PubMed ID: 2582458
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.
    Elashry-Stowers D; Zava DT; Speers WC; Edwards DP
    Cancer Res; 1988 Nov; 48(22):6462-74. PubMed ID: 3180062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone receptors and Japanese breast cancer.
    Matsumoto K; Kitamura Y; Sugano H
    Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in structure of progestins and their binding to progesterone receptors.
    Cabeza M; Heuze Y; Sánchez A; Garrido M; Bratoeff E
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):152-9. PubMed ID: 24666307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
    Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
    Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
    Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
    Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroid receptors in gynecologic cancer.
    Hoffman PG; Siiteri PK
    Obstet Gynecol; 1980 May; 55(5):648-52. PubMed ID: 6988749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steroid hormone receptors in breast cancer].
    Nomura Y
    Rinsho Byori; 1990 Jan; 38(1):26-30. PubMed ID: 2308219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM
    Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal technique to aid decision on endocrine therapy in breast cancer.
    Müller-Holzner E; Zeimet A; Müller LC; Daxenbichler G; Dapunt O
    Lancet; 1989 May; 1(8647):1147-8. PubMed ID: 2566098
    [No Abstract]   [Full Text] [Related]  

  • 15. [Enzymo-immunoassay of progesterone receptors in human breast lesions and tumors. Comparison with a biochemical method].
    Delarue JC; Bertin F; May-Levin F; Mouriesse H
    Bull Cancer; 1989; 76(3):329-32. PubMed ID: 2660942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy, progesterone and progestins in relation to breast cancer risk.
    Campagnoli C; Abbà C; Ambroggio S; Peris C
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):441-50. PubMed ID: 16249080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
    Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical determination of estrogen receptors in breast carcinoma tissue using monoclonal antibodies. 1st clinical findings].
    Jonat W; Stegner HE; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):473-6. PubMed ID: 3896915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal aspects of endometrial cancer.
    Sutton G
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):69-73. PubMed ID: 2102309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptors in normal breast development and breast cancer.
    Giulianelli S; Lamb CA; Lanari C
    Essays Biochem; 2021 Dec; 65(6):951-969. PubMed ID: 34061163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.